Steris (STE) Gains from Investment Securities (2018 - 2025)
Steris has reported Gains from Investment Securities over the past 8 years, most recently at -$12.1 million for Q4 2025.
- Quarterly results put Gains from Investment Securities at -$12.1 million for Q4 2025, down 3933.33% from a year ago — trailing twelve months through Dec 2025 was -$14.9 million (up 8.3% YoY), and the annual figure for FY2025 was -$5.7 million, up 53.43%.
- Gains from Investment Securities for Q4 2025 was -$12.1 million at Steris, down from $14.4 million in the prior quarter.
- Over the last five years, Gains from Investment Securities for STE hit a ceiling of $20.1 million in Q1 2022 and a floor of -$17.8 million in Q1 2023.
- Median Gains from Investment Securities over the past 5 years was -$1.2 million (2021), compared with a mean of -$1.6 million.
- Biggest five-year swings in Gains from Investment Securities: skyrocketed 5007.07% in 2022 and later tumbled 3933.33% in 2025.
- Steris' Gains from Investment Securities stood at $9.5 million in 2021, then crashed by 147.16% to -$4.5 million in 2022, then skyrocketed by 97.06% to -$132000.0 in 2023, then crashed by 127.27% to -$300000.0 in 2024, then tumbled by 3933.33% to -$12.1 million in 2025.
- The last three reported values for Gains from Investment Securities were -$12.1 million (Q4 2025), $14.4 million (Q3 2025), and -$14.5 million (Q2 2025) per Business Quant data.